Single payer advocates
typically use two primary arguments to support a single payer system:
1) The US system is more expensive per patient than single payer systems, and
2) Health outcomes are better for those in single payer systems
1) The US system is more expensive per patient than single payer systems, and
2) Health outcomes are better for those in single payer systems
It is necessary to
understand these issues before coming to the conclusion a single payer system
will correct these problems.
In truth, health outcomes in the United States are far better than those of single payer nations. Further, the cost of care in the United States is the result of government interventions for over a century. The difference is the single payer systems have the means to control expenses through the rationing of care.
In truth, health outcomes in the United States are far better than those of single payer nations. Further, the cost of care in the United States is the result of government interventions for over a century. The difference is the single payer systems have the means to control expenses through the rationing of care.
Every government-run
healthcare system around the world rations care to control costs. In Great
Britain, the National Institute on Clinical Effectiveness makes such decisions,
including a controversial determination that certain cancer drugs are “too expensive.”
The government effectively puts a price tag on each citizen’s life—some $44,305
per year, to be exact. That’s just a baseline, of course, and, as the British
Institute’s chairman, Michael Rawlins, points out, the agency has at times
approved treatments costing as much as $70,887 per year of extended life. But
these are approved only if it can be shown they extend life by at least three
months and are used for illnesses that affect fewer than 7,000 new patients per
year.
This is the reality of socialized medicine. But the mercantile system in the US is little better as noted in this quote describing the problems with the US system:
This is the reality of socialized medicine. But the mercantile system in the US is little better as noted in this quote describing the problems with the US system:
Both the current
public and private insurance systems main techniques for holding down costs are
practicing third party rationing by limiting the services covered, price
controls by constraining payments to providers, and shifting costs to patients.
But given the system's fragmentation and perverse incentives, much
cost-effective care is squeezed out, resources are increasingly allocated to
costly, inefficient and opaque administrative and regulatory procedures and
central organizational overgrowth with un-necessary and in-efficient
micro-management of physicians rather than medical need. The system wastes
money on unnecessary premium care workups for all patients, and inappropriate
use of expensive technology. Other inefficiencies include information failures,
inefficient moral hazard issues, adverse selection, distorted incentives,
inflated hospital and pharmaceutical pricing and cost shifting. Many attainable
efficiencies are not achieved. We also use medicines and technologies that cost
a lot for little or no marginal health benefit. Administrative expenses are
high, and enormous sums are squandered in efforts to game the system. Given the
mercantile emphasis on production and the ignored consumer it is no wonder that
between one fifth and one third of medical outlays do nothing to improve
health.[i]
So, what then is the
answer to this? More government, the same government which created the US
system we have now? "What? The US did not create our healthcare
system", you are probably saying. Indeed it did and is described in this article.
But managed care and our current single payer government systems, Medicare and
Medicaid, are not fixing what is broken.
Cookbook medicine does not contain costs. All current cost containment
strategies are failing.
For a more detailed
explanation of how government created the system we have, it started about 100
years ago with medical licensing laws which created a crony relationship
between the American Medical Association (AMA) and government which removed
competition from within the medical community. Dr. Michel Accad, M.D. describes
this in detail in his healthcare blog, alertandoriented.com. In it, he describes the transition of
healthcare following the Flexner Report in 1910. He goes into detail concerning
the results of the report:
The
main effect of the report was to change public and political opinion about
medical education and to influence the implementation of strict licensing laws.
The change in sentiment was facilitated by the political and financial
influence of organizations such as the Carnegie Corporation and the Rockefeller
Foundation.
In
the wake of the report, and under the lobbying efforts of the AMA,
states rapidly established medical acts to regulate the issuance of medical
licenses. Henceforth, licenses would only be given to graduates of
schools that met criteria set forth by the Flexner report. Those
medical schools would have to be accredited by the Liaison Committee on Medical Education, a joint
venture of the AMA and its close ally, the American Association of Medical
Colleges.
From
an economic standpoint, what happened next was a period of severe medical
price inflation which occurred quickly and dramatically. The situation
was so serious that in 1925, a national Committee on the Costs of Medical Care
(CCMC) was organized to address the question.
The
CCMC was also funded by the Carnegie Corporation and by a number of other
private foundations, such as the Rockefeller Foundation. The
committee received material assistance from the AMA, the American
Hospital Association, and other leading professional organizations, as well as
from many government agencies, including the National Bureau of Economic
Research. Numerous reports were issued over the next few years, and
those were compiled in 1932 into a large volume entitled The Costs of Medical Care.
The
CCMC confirmed that the costs of medical care had risen dramatically in the
prior years. The committee also found that health care
disparities had increased, with access to medical care in rural and poor areas
being particularly problematic.[ii]
Coinciding with the
Flexner Reforms was the active effort by the government to terminate the
relationship people had with
mutual assistance organizations. Mutual
assistance organizations used to be a source for primary care for working poor
across the country. Lodge practice was
the means by which doctors provided primary care to members of these
organizations. Removing primary care as
a benefit to lodge membership, by making lodge practice illegal, forced people
to pay for care out of pocket.
"Lodge
practice" refers to an arrangement, reminiscent of today's HMOs, whereby a
particular society or lodge would contract with a doctor to provide medical
care to its members. The doctor received a regular salary on a retainer basis,
rather than charging per item; members would pay a yearly fee and then call on
the doctor's services as needed. If medical services were found unsatisfactory,
the doctor would be penalized, and the contract might not be renewed.
Most remarkable was the low cost at which these medical services were provided. At the turn of the century, the average cost of "lodge practice" to an individual member was between one and two dollars a year. A day's wage would pay for a year's worth of medical care. By contrast, the average cost of medical service on the regular market was between one and two dollars per visit. Yet licensed physicians, particularly those who did not come from "big name" medical schools, competed vigorously for lodge contracts, perhaps because of the security they offered; and this competition continued to keep costs low.
The response of the medical establishment, both in America and in Britain, was one of outrage; the institution of lodge practice was denounced in harsh language and apocalyptic tones. Such low fees, many doctors charged, were bankrupting the medical profession. Moreover, many saw it as a blow to the dignity of the profession that trained physicians should be eagerly bidding for the chance to serve as the hirelings of lower-class tradesmen. It was particularly detestable that such uneducated and socially inferior people should be permitted to set fees for the physicians' services, or to sit in judgment on professionals to determine whether their services had been satisfactory. The government, they demanded, must do something.
Most remarkable was the low cost at which these medical services were provided. At the turn of the century, the average cost of "lodge practice" to an individual member was between one and two dollars a year. A day's wage would pay for a year's worth of medical care. By contrast, the average cost of medical service on the regular market was between one and two dollars per visit. Yet licensed physicians, particularly those who did not come from "big name" medical schools, competed vigorously for lodge contracts, perhaps because of the security they offered; and this competition continued to keep costs low.
The response of the medical establishment, both in America and in Britain, was one of outrage; the institution of lodge practice was denounced in harsh language and apocalyptic tones. Such low fees, many doctors charged, were bankrupting the medical profession. Moreover, many saw it as a blow to the dignity of the profession that trained physicians should be eagerly bidding for the chance to serve as the hirelings of lower-class tradesmen. It was particularly detestable that such uneducated and socially inferior people should be permitted to set fees for the physicians' services, or to sit in judgment on professionals to determine whether their services had been satisfactory. The government, they demanded, must do something.
And so it did. In
Britain, the state put an end to the "evil" of lodge practice by
bringing health care under political control. Physicians' fees would now be
determined by panels of trained professionals (i.e., the physicians
themselves) rather than by ignorant patients. State-financed medical care edged
out lodge practice; those who were being forced to pay taxes for
"free" health care whether they wanted it or not had little incentive
to pay extra for health care through the fraternal societies, rather than using
the government care they had already paid for.
In America, it
took longer for the nation's health care system to be socialized, so the
medical establishment had to achieve its ends more indirectly; but the
essential result was the same. Medical societies like the AMA imposed sanctions
on doctors who dared to sign lodge practice contracts. This might have been
less effective if such medical societies had not had access to government
power; but in fact, thanks to governmental grants of privilege, they controlled
the medical licensure procedure, thus ensuring that those in their disfavor
would be denied the right to practice medicine.
Such licensure
laws also offered the medical establishment a less overt way of combating lodge
practice. It was during this period that the AMA made the requirements for
medical licensure far more strict than they had previously been. Their reason,
they claimed, was to raise the quality of medical care. But the result was that
the number of physicians fell, competition dwindled, and medical fees rose; the
vast pool of physicians bidding for lodge practice contracts had been
abolished. As with any market good, artificial restrictions on supply created
higher prices — a particular hardship for the working-class members of
fraternal societies.[iii]
Then, along comes
WWII and government policies which connected health insurance with one's
employer and began the 3rd party payer system we have made into law with ACA.
It started with wartime wage freezes. Employers desperate to entice employees used health insurance benefits as an enticement since wages were frozen by law.[iv] After the war, the tax code was altered to give tax benefits to employers for providing health insurance.[v] So, what happens over time is that individual ownership of health insurance policies ownership slows or stops while simultaneously premiums and costs begin to go up. Why? Because now insurance pays for everything and the user does not even pay for the insurance. Prices are the means of communicating value, but with healthcare, prices are irrelevant as a result of the 3rd party payer system. This video briefly describes the problem.
It started with wartime wage freezes. Employers desperate to entice employees used health insurance benefits as an enticement since wages were frozen by law.[iv] After the war, the tax code was altered to give tax benefits to employers for providing health insurance.[v] So, what happens over time is that individual ownership of health insurance policies ownership slows or stops while simultaneously premiums and costs begin to go up. Why? Because now insurance pays for everything and the user does not even pay for the insurance. Prices are the means of communicating value, but with healthcare, prices are irrelevant as a result of the 3rd party payer system. This video briefly describes the problem.
Because
insurance companies are — partly — obligated to pay for any expenses of their
customers, and the inability of customers to establish what the real prices of
their services provided are — something readily available in a real free market
— prices are able to rise far beyond what would be the case in a free market
with functioning price signals. Because governments, through taxation, pay for
the largest part of these health insurance schemes, we as consumers are not
aware of the total costs of these medical services. This lack of awareness in
turn contributes to the possibilities of rising prices for medical services.[vi]
But
then, what happens when one needs to change jobs for better money or
whatever...fine, if you are healthy but not if you are sick. Voila, the
pre-existing condition problem. Again, the result of employer provided
insurance which had been incentivized by government wage and tax policy. So,
what happens when one retires from all but a handful of the largest employers
which have healthcare plans for retirees? Since the insurance was employer
provided and not individually owned, no more insurance at retirement. Add to
this the expense at that point of trying to obtain insurance, which at 65 is
not cheap, and you have the need for Medicare. Again, a problem caused by
government.
So along comes the HMO law the brainchild of Ted Kennedy[vii]. "Combined with Medicare, the HMO Act eventually eliminated the market for affordable individual health insurance".[viii] Within 20 years of that law, the system is hopelessly damaged and the 3rd party payer system is the rule. Do not also forget the prices of policies are forced up by numerous mandates by both the states and federal government.[ix] Pricing for medical services is almost universally based on Medicare pricing[x] and policy pricing is regulated by the states[xi]. Thus, bureaucrats have decided what the value of a medical service will be, not the market and there is no pricing mechanism to transmit information.
So along comes the HMO law the brainchild of Ted Kennedy[vii]. "Combined with Medicare, the HMO Act eventually eliminated the market for affordable individual health insurance".[viii] Within 20 years of that law, the system is hopelessly damaged and the 3rd party payer system is the rule. Do not also forget the prices of policies are forced up by numerous mandates by both the states and federal government.[ix] Pricing for medical services is almost universally based on Medicare pricing[x] and policy pricing is regulated by the states[xi]. Thus, bureaucrats have decided what the value of a medical service will be, not the market and there is no pricing mechanism to transmit information.
ACA
made the 3rd party payer system, which was already failing, into law by
mandating employers offer those benefits. In other words, ACA doubled down on
failure. ACA creates an illusion of having elements of the free
market in the form of the exchanges and when the system begins to fail, as it
is now, the blame can be laid on the failure of markets so as to usher in a
single payer system.
One of the big justifications used by many advocating a single payer system is that in single payer countries, the health of the people is better. Health outcomes in those countries are in fact not better than those in the United States.
One of the big justifications used by many advocating a single payer system is that in single payer countries, the health of the people is better. Health outcomes in those countries are in fact not better than those in the United States.
For example, life
expectancies are affected by exogenous factors such as violent crime, poverty,
obesity, tobacco and drug use, and other issues unrelated to health care. As
the Organization for Economic Co-operation and Development explains, “It is
difficult to estimate the relative contribution of the numerous nonmedical
and medical factors that might affect variations in life expectancy across
countries and over time.”[xii]
Similarly, infant mortality, a common measure in cross-country comparisons, is highly problematic. In the United States, very low birth-weight infants have a much greater chance of being brought to term with the latest medical technologies. Some of those low birth-weight babies die soon after birth, which boosts our infant mortality rate, but in many other Western countries, those high-risk, low birth-weight infants are not included when infant mortality is calculated.[xiii]
When you compare the outcomes for specific diseases, the United States clearly outperforms the rest of the world. Whether the disease is cancer, pneumonia, heart disease, or AIDS, the chances of a patient surviving are far higher in the United States than in other countries. For example, according to a study published in the British medical journal The Lancet, the United States is at the top of the charts when it comes to surviving cancer. Among men, roughly 62.9 percent of those diagnosed with cancer survive for at least five years.[xiv] The news is even better for women: the five year-survival rate is 66.3 percent, or two thirds. The countries with the next best results are Iceland for men (61.8 percent) and Sweden for women (60.3 percent). Most countries with national health care fare far worse.[xv]
Moreover, the United States drives much of the innovation and research on health care worldwide. Eighteen of the last 25 winners of the Nobel Prize in Medicine are either U.S. citizens or individuals working here.[xvi] U.S. companies have developed half of all new major medicines introduced worldwide over the past 20 years.[xvii] In fact, Americans played a key role in 80 percent of the most important medical advances of the past 30 years.[xviii] Advanced medical technology is far more available in the United States than in nearly any other country.
By the same token, not only do thousands of foreign-born doctors come to the United States to practice medicine, but foreign pharmaceutical companies fleeing taxes, regulation, and price controls are increasingly relocating to the United States.[xix] In many ways, the rest of the world piggybacks on the U.S. system.
Similarly, infant mortality, a common measure in cross-country comparisons, is highly problematic. In the United States, very low birth-weight infants have a much greater chance of being brought to term with the latest medical technologies. Some of those low birth-weight babies die soon after birth, which boosts our infant mortality rate, but in many other Western countries, those high-risk, low birth-weight infants are not included when infant mortality is calculated.[xiii]
When you compare the outcomes for specific diseases, the United States clearly outperforms the rest of the world. Whether the disease is cancer, pneumonia, heart disease, or AIDS, the chances of a patient surviving are far higher in the United States than in other countries. For example, according to a study published in the British medical journal The Lancet, the United States is at the top of the charts when it comes to surviving cancer. Among men, roughly 62.9 percent of those diagnosed with cancer survive for at least five years.[xiv] The news is even better for women: the five year-survival rate is 66.3 percent, or two thirds. The countries with the next best results are Iceland for men (61.8 percent) and Sweden for women (60.3 percent). Most countries with national health care fare far worse.[xv]
Moreover, the United States drives much of the innovation and research on health care worldwide. Eighteen of the last 25 winners of the Nobel Prize in Medicine are either U.S. citizens or individuals working here.[xvi] U.S. companies have developed half of all new major medicines introduced worldwide over the past 20 years.[xvii] In fact, Americans played a key role in 80 percent of the most important medical advances of the past 30 years.[xviii] Advanced medical technology is far more available in the United States than in nearly any other country.
By the same token, not only do thousands of foreign-born doctors come to the United States to practice medicine, but foreign pharmaceutical companies fleeing taxes, regulation, and price controls are increasingly relocating to the United States.[xix] In many ways, the rest of the world piggybacks on the U.S. system.
Health and medicine
present unique challenges but non-coercive measures are best able to address
these challenges. A comprehensive functional market-based system is far better
positioned to match resources without price controls or rationing care. A market-based
system suffers far less of the feast-or-famine misallocation of resources
driven by our current mercantile system. It also saves huge sums that our
current system wastes on administration, physician micro-management, billing,
excessive executive compensation, and risk selection signing up only the
healthy and wealthy leaving the sick and poor to be paid at the maximum rate by
the American taxpayer.
[i] Lanzalotti, M.D., J. (2011). Jeffersonian
Health Policy Foundation -Single Payer vs. Market System. [online]
Jhpf.org. Available at: http://www.jhpf.org/research/healthcare/singlepayer.asp
[Accessed 10 Jan. 2020].
[ii] Accad, M.D., M. (2015). An
economic history of the American health care system-Part 1 | Alert &
Oriented. [online] Alert & Oriented. Available at:
http://alertandoriented.com/an-economic-history-of-the-american-health-care-system-part-1/
[Accessed 10 Jan. 2020].
[iii] Long, R. (1993). How Government
Solved the Health Care Crisis. [online] Freenation.org. Available at:
http://www.freenation.org/a/f12l3.html [Accessed 10 Jan. 2020].
[iv]
Institute of Medicine (US) Committee on Employment-Based Health Benefits; Field
MJ, Shapiro HT, editors. Employment and Health Benefits: A Connection at Risk.
Washington (DC): National Academies Press (US); 1993. 2, Origins and Evolution
of Employment-Based Health Benefits. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK235989/
[v]
Ibid
[vi] Cornax,
W. (2014). How Third-Party Payers Drive Up Medical Costs | Willem G. Cornax.
[online] Mises Institute. Available at: https://mises.org/library/how-third-party-payers-drive-medical-costs
[Accessed 11 Jan. 2020].
[vii] En.wikipedia.org.
(2019). Health Maintenance Organization Act of 1973. [online] Available
at: https://en.wikipedia.org/wiki/Health_Maintenance_Organization_Act_of_1973
[Accessed 11 Jan. 2020].
[viii]
Holleran, S. (1999). The History of HMOs - Capitalism Magazine. [online]
Capitalism Magazine. Available at:
http://capitalismmagazine.com/1999/11/the-history-of-hmos/ [Accessed 11 Jan.
2020].
[ix] New,
Michael J, Ph.D (2005). The Effect of State Regulations on Health Insurance Premiums:
A Preliminary Analysis, Center for Data Analysis, CDA05-07, October 27, 2005
[x] Roger
Feldman, Bryan Dowd, and Robert Coulam. “Medicare’s Role in Determining Prices
throughout the Health Care System.” Mercatus Working Paper, Mercatus Center at
George Mason University, Arlington, VA, October 2015.
[xi] New,
Michael J, Ph.D (2005). The Effect of State Regulations on Health Insurance Premiums:
A Preliminary Analysis, Center for Data Analysis, CDA05-07, October 27, 2005
[xii] OECD,
“Health at a Glance: OECD Indicators, 2005” (Paris: OECD Publishing, 2005),
p.11
[xiii]
World Health Statistics Quarterly 36 (1983), cited in Nicholas Eberstadt, The
Tyranny of Numbers: Measurements and Misrule (Washington: AEI Press, 1995), p.
50.
[xiv] Arduino
Verdecchia et al., “Recent Cancer Survival in Europe: A 2000–02 Period Analysis
of EUROCARE-4 Data,” The Lancet Oncology 8, no. 9 (2007): 784–96,
http://www.thelancet.com
/journals/lanonc/article/PIIS1470204507702462/abstract
[xv] Nicole
Martin, “UK Cancer Survival Rate Lowest in Europe,” Daily Telegraph, August 24,
2007.
[xvi] “Nobel
Prize in Physiology or Medicine Winners 2007–1901,” The Nobel Prize Internet
Archive, http://almaz.com /nobel/medicine/medicine.html.
[xvii]
“Pharmaceutical Research and Manufacturing of America,“ R&D Spending by
U.S. Biopharmaceutical Companies Reaches a Record $55.2 Billion in 2006,”
February 12, 2007.
[xviii]
Economic Report of the President (Washington: Government Printing Office,
2004), p. 192.
[xix] “The
Novartis Warning,” Wall Street Journal, May 8, 2002